Showing 2 of 2 recruiting trials for “T-cell prolymphocytic leukemia”
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
RecruitingNCT04411043 ↗
Observatory of Prolymphocytic Leukemia T
👨⚕️ Kamel LARIBI, Dr, French Innovative Leukemia Organisation📍 1 site📅 Started Jul 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →